Exchange Commission No. Sor Nor. 88/2558 Re: Prospectus for Offering of Investment Units of Retail Mutual Funds, Mutual Funds for Accredited Investors and Mutual Funds for Institutional Investors
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
., Ltd and appointment of member of audit committee. (Revised) To: President The Stock Exchange of Thailand Enclosure: Information Memorandum regarding the Acquisition of Asset of Demeter Corporation
and Allocation of Securities to the Specific Investor (Private Placement) To The President The Stock Exchange of Thailand Attachment 1. Information Memorandum regarding the Acquisition of Assets and
memorandum on execution of the connected transaction to the Stock Exchange of Thailand, and also seek approval from the Shareholders’ Meeting with the favorable votes of not less than three-fourths of all
Exchange of Thailand, and also seek approval from the Shareholders’ Meeting with the favorable votes of not less than three-fourths of all votes of the shareholders attending the Meeting and having the
memorandum on execution of the connected transaction to the Stock Exchange of Thailand, and also seek approval from the Shareholders’ Meeting with the favorable votes of not less than three-fourths of all
of the Securities and Exchange Act B.E. 2535 (1992) , as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008) , Paragraph 2 of Section 100, Section 114, Section 115, Section 116 and
of the Securities and Exchange Act B.E. 2535 (1992), as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008), Paragraph 2 of Section 100, Section 114, Section 115, Section 116 and
of the Securities and Exchange Act B.E. 2535 (1992), as amended by the Securities and Exchange Act (No. 4) B.E. 2551 (2008), Paragraph 2 of Section 100, Section 114, Section 115, Section 116 and